Japanese Stock News

TSE:218A
TSE:218AProfessional Services

Liberaware Q2 2026 EPS Return To Profit Tests Bearish Volatility Narratives

Liberaware (TSE:218A) has just posted its Q2 2026 scorecard, reporting revenue of ¥402.71 million and basic EPS of ¥4.75. The trailing twelve month figures show revenue of ¥1,488.82 million and basic EPS of ¥11.79. The company has recorded quarterly revenue between ¥307.57 million and ¥426.84 million over the past six reported periods, with EPS ranging from a loss of ¥57.07 to a gain of ¥72.58 before arriving at the latest ¥4.75 figure. This variability puts the focus on how sustainable...
TSE:6037
TSE:6037Interactive Media and Services

RAKUMACHIInc (TSE:6037) Net Margin At 37% Reinforces Bullish Earnings Narratives

RAKUMACHIInc (TSE:6037) has released its H1 2026 results, reporting revenue of ¥1,757 million and basic EPS of ¥36.43, alongside net income of ¥721 million, setting the tone for the latest earnings season update. The company’s revenue has moved from ¥1,529 million in H1 2025 to ¥1,630 million in H2 2025 and then to ¥1,757 million in H1 2026, while basic EPS has progressed from ¥24.66 to ¥31.54 and then ¥36.43 over the same halves, giving investors a clear view of how the top and bottom lines...
TSE:3662
TSE:3662Entertainment

Ateam Holdings Q2 Loss And Margin Compression Challenge Bullish Growth Narratives

Ateam Holdings (TSE:3662) has just posted Q2 2026 results, with revenue of ¥5,790 million and a net loss of ¥66 million, translating to basic EPS of ¥3.55. The company has seen quarterly revenue move within a relatively tight band from ¥5,677 million in Q1 2025 to ¥6,429 million in Q3 2025. Basic EPS has swung from a profit of ¥25.21 in Q3 2025 to a modest ¥0.48 in Q4 2025 and a loss this quarter, keeping margins and earnings quality firmly in focus for investors. See our full analysis for...
TSE:8308
TSE:8308Banks

A Look At Resona Holdings (TSE:8308) Valuation As Leadership Roles Are Realigned

Resona Holdings (TSE:8308) is reshaping its leadership, with the board approving promotions that place long serving insiders Shinichiro Isa and Nobuki Iwadate into expanded Deputy President roles. See our latest analysis for Resona Holdings. These leadership changes come as Resona Holdings trades at ¥1,747.5, with a 1 day share price return of 1.27%, a 30 day share price return decline of 19.08%, and a 1 year total shareholder return of 37.59%, suggesting longer term momentum remains stronger...
TSE:9697
TSE:9697Entertainment

Did Capcom’s (TSE:9697) Resident Evil PC Tie-in and Leadership Shuffle Just Reframe Its IP Strategy?

GIGABYTE recently announced a collaboration with Capcom to promote the upcoming Resident Evil Requiem game through a themed custom PC giveaway and bundled monitor-game offers, while Capcom’s board approved director changes and new management roles effective April 1, 2026. Together, the gaming hardware tie-in and leadership reshuffle highlight how Capcom is leaning on flagship IP while refining its internal business focus. We’ll now examine how the Resident Evil Requiem collaboration with...
TSE:6971
TSE:6971Electronic

A Look At Kyocera (TSE:6971) Valuation After Recent Share Price Pullback

Kyocera stock moves after recent performance Kyocera (TSE:6971) has attracted attention after a 1 day decline of 1.4%, following a 4.1% fall over the past week, even though the share price shows a 12.7% gain over the past 3 months. See our latest analysis for Kyocera. Short term momentum has cooled, with the 7 day and 30 day share price returns both negative. However, the 90 day gain of 12.7% and 1 year total shareholder return of 54.3% still indicate stronger performance over a longer...
TSE:9984
TSE:9984Wireless Telecom

Reassessing SoftBank Group (TSE:9984) After Recent Share Price Slide And AI Narrative Shifts

Wondering whether SoftBank Group's current share price actually lines up with its underlying value? This article walks through the numbers so you can see how the market is pricing the story. The stock closed at ¥3,578 after an 8.9% decline over the last 7 days, a 24.0% drop over 30 days and a 22.5% fall year to date, while the 1 year return sits at 83.4% and the 3 year return is very large at about 3x. These swings have come as SoftBank Group continues to be closely watched as a major...
TSE:3350
TSE:3350Hospitality

Metaplanet (TSE:3350) Is Up 9.4% After Launching Bitcoin-Focused Metaplanet Ventures K.K. - What's Changed

Earlier this month, Metaplanet Inc. approved the creation of a wholly owned subsidiary, Metaplanet Ventures K.K., committing about ¥4,000 million over two to three years to invest in Bitcoin financial infrastructure, incubate early-stage domestic projects, and fund Bitcoin-focused grants in Japan. This move effectively turns Metaplanet into a corporate backer of Japan’s regulated Bitcoin ecosystem, linking its Bitcoin income business directly to venture, incubator, and developer-support...
TSE:4502
TSE:4502Pharmaceuticals

Takeda Pharmaceutical (TSE:4502) Valuation Check After Strong 1 Year Return And Conflicting Fair Value Signals

Takeda Pharmaceutical stock snapshot Takeda Pharmaceutical (TSE:4502) has drawn investor attention after a period of steady trading, with its share price around ¥5,673 and multi year total returns along with recent revenue and net income figures in focus. See our latest analysis for Takeda Pharmaceutical. At around ¥5,673 per share, Takeda Pharmaceutical has delivered a 90 day share price return of 27.54%, while its 1 year total shareholder return of 33.82% points to building momentum beyond...
TSE:6702
TSE:6702IT

Fujitsu’s AI Infrastructure Alliance With Arrcus and 1Finity Could Be A Game Changer For Fujitsu (TSE:6702)

In early March 2026, Arrcus announced a collaboration with Fujitsu and 1Finity to combine FUJITSU-MONAKA Arm-based CPUs, ArcOS software-defined networking, and high-speed optical interconnects into a secure, energy-efficient infrastructure for distributed AI workloads from edge inference to large-scale training. This partnership highlights Fujitsu’s push to align compute, networking, and optical transport for emerging Physical and enterprise AI use cases such as smart factories, robotics,...
TSE:8002
TSE:8002Trade Distributors

Assessing Marubeni’s Valuation As The Branford Castle Partnership Expands Global Investment Reach

Why Marubeni’s Branford Castle deal matters for shareholders Marubeni (TSE:8002) has drawn investor attention after committing capital to Branford Castle Partners’ new flagship fund and agreeing to work alongside the firm to source and support global investment opportunities. See our latest analysis for Marubeni. The Branford Castle agreement lands while Marubeni’s share price sits at ¥5,591, with a 1 day share price return of 4.02% and 7 day return of 3.86%. However, the 30 day share price...
TSE:6645
TSE:6645Electronic

Omron’s SF2030 Plan Targets Data Growth In Automation And Healthcare

OMRON (TSE:6645) has released its SF2030 2nd Stage medium term plan, outlining a broad shift toward data driven operations. The plan highlights increased focus on industrial automation, healthcare, and targeted growth in Europe. This roadmap sets out multi year priorities for redirecting investment and reshaping the company’s business mix. OMRON, trading at ¥4,532.0, enters this new phase after a mixed share price record, with a 13.4% return year to date and a 3.5% return over 1 year,...
TSE:5631
TSE:5631Machinery

Will Nuclear-Focused Capacity Expansion at Japan Steel Works (TSE:5631) Reshape Its Long-Cycle Growth Narrative?

Japan Steel Works recently moved to expand its production capacity to serve rising orders from the recovering global nuclear energy sector, reinforcing its role in supplying advanced components and industrial machinery. This capacity build-out highlights how Japan Steel Works is tying its engineering and manufacturing expertise more closely to long-cycle nuclear infrastructure projects worldwide. We will now examine how this nuclear-focused capacity expansion shapes Japan Steel Works’...
TSE:5801
TSE:5801Electrical

Is Furukawa Electric’s (TSE:5801) Leadership Reshuffle Quietly Redefining Its Core Technology Strategy?

Furukawa Electric has announced extensive executive transfers, new duties, and board director candidates following its March 5 Board of Directors meeting, with many changes taking effect from April 1 and further transitions planned through June 26, 2026. The reshuffle concentrates leadership around key domains such as digital infrastructure components, automotive systems, and energy infrastructure, suggesting a sharpened focus on technology-driven and infrastructure-related businesses. Next,...
TSE:5803
TSE:5803Electrical

Assessing Fujikura (TSE:5803) Valuation After New PRIZM TMT Data Center Connectivity Agreements

Why Fujikura’s latest fiber optics moves matter for shareholders Fujikura (TSE:5803) has been in focus after new agreements with US Conec, Corning and Sumitomo Electric Lightwave to extend the MMC VSFF platform using PRIZM TMT expanded beam optics for high density connectivity. See our latest analysis for Fujikura. The PRIZM TMT agreements come at a time when momentum in Fujikura’s shares has been strong, with a 30 day share price return of 15.0% and a year to date share price return of...
TSE:4118
TSE:4118Chemicals

Does Kaneka’s Toro 88 Superbore Catheter Launch Deepen Its Neurovascular Ambitions For Kaneka (TSE:4118)?

Toro Neurovascular previously announced that the U.S. FDA had granted 510(k) clearance for its Toro 88 Superbore Catheter, with Kaneka Medical America LLC leading the U.S. commercial launch following the device’s first successful clinical use by Dr. Satoshi Tateshima. This launch underscores Kaneka’s deeper involvement in the neurovascular device market, pairing Toro’s catheter technology with Kaneka’s established U.S. sales and clinical support network. We’ll now examine how Kaneka’s role...
TSE:3626
TSE:3626IT

TIS (TSE:3626) Is Up 7.1% After Launching ¥50 Billion Share Buyback With Possible Cancellation

On March 10, 2026, TIS Inc. (TSE:3626) announced a share repurchase program of up to 20,000,000 shares, or 8.76% of outstanding shares, for ¥50,000 million running through September 30, 2026, with any repurchased shares above 5% of issued shares to be cancelled. This buyback, framed as a way to enhance shareholder returns and capital efficiency, could meaningfully reshape TIS’s balance between growth investment and capital return. We will examine how TIS’s sizeable share repurchase plan,...
TSE:8058
TSE:8058Trade Distributors

How Frontier Lithium’s PAK MOU Could Shape Mitsubishi’s North American Battery Role (TSE:8058)

In March 2026, Frontier Lithium announced it had signed a non-binding Memorandum of Understanding with Panasonic Energy and Mitsubishi to explore lithium hydroxide procurement and broader collaboration around the PAK Lithium Project in Ontario, aimed at supplying North America’s electric vehicle battery supply chain from 2030. A key insight is that Mitsubishi’s existing joint venture role in the PAK Lithium Project now sits within a wider potential offtake and technical cooperation framework...
TSE:6674
TSE:6674Auto Components

Assessing GS Yuasa (TSE:6674) Valuation After Strong Recent Share Price Momentum

GS Yuasa (TSE:6674) has drawn fresh attention after recent share price moves, prompting investors to reassess how its current valuation lines up with reported fundamentals such as revenue, earnings and its value score of 4. See our latest analysis for GS Yuasa. At a share price of ¥5,193, GS Yuasa’s recent 1 month share price return of 15.99% and year to date share price return of 36.66% point to building momentum. The 1 year total shareholder return of 114.20% highlights how price gains and...
TSE:6920
TSE:6920Semiconductor

Lasertec (TSE:6920) Is Up 12.7% After Surprise Surge In Chip Inspection Tool Orders – What's Changed

In March 2026, Lasertec drew heightened attention after reports of stronger-than-expected order momentum for its semiconductor inspection and wafer metrology equipment, following a sharp sector-wide selloff tied to inflation concerns. This sequence of macro-driven weakness followed by renewed product-focused interest highlights how quickly sentiment can swing around Lasertec’s core inspection business. We’ll now examine how this stronger-than-expected order momentum for semiconductor...
TSE:3407
TSE:3407Chemicals

Is Asahi Kasei (TSE:3407) Still Attractive After Its Strong Multi Year Share Price Run

If you are wondering whether Asahi Kasei is still good value after its recent run, you are not alone. The key question now is how the current share price lines up with the underlying business. The stock closed at ¥1,616.5, with returns of 13.8% year to date, 60.5% over 1 year, 94.7% over 3 years and 38.5% over 5 years, although it has seen a 5.6% decline over the last 7 days and a 6.9% decline over the last 30 days. Recent news coverage around Asahi Kasei has focused on its position in the...
TSE:7203
TSE:7203Auto

Toyota Solid State Battery Push Reframes Long Term Investment Story

Toyota Motor (TSE:7203) is ramping up investment in solid-state battery technology. The company is preparing for potential mass production within the next two years. This push positions Toyota for a possible shift in how electric vehicles are powered and designed. Toyota is best known for its hybrid leadership, and this solid-state battery move adds a new angle to its electric vehicle plans. As global automakers compete to improve driving range, charging times, and battery safety, a...
TSE:3064
TSE:3064Trade Distributors

Assessing MonotaRO (TSE:3064) Valuation After Strong February 2026 Sales Update

February sales update draws fresh attention to MonotaRO MonotaRO (TSE:3064) has attracted fresh attention after reporting preliminary non-consolidated February 2026 sales of ¥28,454 million, compared with ¥24,262 million in February 2025. This provides investors with a timely read on current business activity. See our latest analysis for MonotaRO. Despite the solid February sales update, MonotaRO’s recent share price performance has been weak. The 30 day share price return shows an 11.82%...
TSE:4151
TSE:4151Pharmaceuticals

Kyowa Kirin (TSE:4151) Valuation Check After Rocatinlimab Trials Are Halted Over Safety Concerns

Kyowa Kirin (TSE:4151) has moved to discontinue all clinical trials of rocatinlimab after a planned safety review highlighted malignancy concerns linked to OX40 pathway modulation, including confirmed and suspected Kaposi’s sarcoma cases. See our latest analysis for Kyowa Kirin. At a share price of ¥2,339, Kyowa Kirin has seen a 1-day share price return of 1.56% and a 7-day gain of 3.89%, compared with a weaker 30-day share price return of a 10.11% decline and a year-to-date share price...